Brii Ups Its Bet On VBI’s Hepatitis B Assets Amid Larger Treatment, Prevention Push

 
• By Alaric DeArment
  
Brii is in-licensing VBI's hepatitis B vaccine • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business